Schering-Plough
SGP
#544
Rank
ยฃ34.22 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Earnings for Schering-Plough (SGP.defunct.2009)

Earnings in 2008: ยฃ1.51 Billion

According to Schering-Plough's latest financial reports the company's current earnings are N/A. In 2008 the company made an earning of ยฃ1.51 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Schering-Plough from 1996 to 2008

Annual earnings

Year Earnings Change
2008ยฃ1.51 B
2006ยฃ1.09 B198.39%
2005ยฃ0.36 B-395.83%
2004-ยฃ0.13 Billion265.22%
2003-ยฃ34.09 Million-102.01%
2002ยฃ1.69 B3.62%
2001ยฃ1.63 B-5.39%
2000ยฃ1.73 B
1998ยฃ1.42 B22.34%
1997ยฃ1.16 B38.9%
1996ยฃ0.84 B